Search

Your search keyword '"Aly, Markus"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Aly, Markus" Remove constraint Author: "Aly, Markus" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
43 results on '"Aly, Markus"'

Search Results

3. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

5. Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group

10. Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists.

11. Prostate Cancer Incidence and Mortality in Men Exposed to α1-Adrenoceptor Antagonists

12. MP14-02 IDENTIFY THE OPTIMAL CANDIDATES FOR ADJUVANT ANDROGEN DEPRIVATION THERAPY AMONG PATIENTS WITH DETECTABLE PSA AFTER RADICAL PROSTATECTOMY

13. PD29-12 THE IMPACT OF THE TIME ELAPSED BETWEEN PRIMARY TREATMENT AND BCR ON CANCER SPECIFIC MORTALITY IN PATIENTS WHO EXPERIENCED BCR AFTER PRIMARY TREATMENT

14. A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer

16. Risk of Venous Thromboembolic Events After Surgery for Cancer

17. Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer

18. Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group

20. Association between early mobilisation after abdominal cancer surgery and postoperative complications

21. Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer

22. Supplementary Methods, Figures S1 - S3 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

23. Supplementary Tables S1 - S10 from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

24. Supplementary Acknowledgments from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

25. Data from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

26. Supplementary Grant Support from Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

27. PD38-11 THE STOCKHOLM3 PROSTATE CANCER SCREENING TRIAL (STHLM3): AN INTERIM ANALYSIS OF MORTALITY RESULTS AFTER 6.5 YEARS OF FOLLOW-UP

28. PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESPONSE

29. MP17-06 VALIDATION OF EAU RISK GROUPS FOR BIOCHEMICAL RECURRENCE AFTER RADIOTHERAPY AND RADICAL PROSTATECTOMY FOR PREDICTION OF PROSTATE CANCER MORTALITY

30. Supplementary notes from Genome-Wide Association Study of Prostate Cancer–Specific Survival

31. Data from Genome-Wide Association Study of Prostate Cancer–Specific Survival

32. Cardiovascular, bone, and metabolic health in men with castrate-resistant prostate cancer treated with androgen deprivation: a matched cohort study

34. Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

38. The 90‐day cause‐specific mortality after radical prostatectomy: a nationwide population‐based study.

41. PD45-06 ACCURACY OF THE MRI 5-POINT LIKERT SCORE TO PREDICT EXTRA-PROSTATIC EXTENSION AND SEMINAL VESICLE INVASION IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER AND DEVELOPMENT OF a NEW MRI-BASED NOMOGRAM.

42. Exercise in primary care after robot-assisted radical cystectomy for urinary bladder cancer - effects on postoperative complications: a secondary analysis of a randomised controlled trial.

43. A population-based registry cohort study on the correlation between bladder-intact event-free survival and overall survival in cystectomy-ineligible/refusal muscle-invasive bladder cancer patients in Sweden.

Catalog

Books, media, physical & digital resources